Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1165 of 1,261
  1. US 6660273

    Chimeric vaccine against tick-borne encephalitis virus

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  2. US 6660499

    DCR5, a BMP-binding protein, and applications thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  3. US 6660484

    Colorimetric glycopolythiophene biosensors

    The Regents of the University of California Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  4. US 6660748

    Bicyclic derivatives

    Vertex Pharmaceuticals Incorporated Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  5. US 6660846

    Vesicular amino acid transporter composition and method

    Regents of the University of CA Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  6. US 6660767

    Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof

    The Regents of the University of California Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  7. US 6660530

    Methods for labeling &bgr;-amyloid plaques and neurofibrillary tangles

    The Regents of the University of California Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  8. US 6660488

    Antibodies for the alpha platelet-derived growth factor receptor

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  9. US 6660731

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Dec 9, 2003 Β· Expires Dec 4, 2023

    expired
  10. WO 03099006

    DESINFECTANT AYANT UNE ACTIVITE CONTRE LE VIRUS DE L'HEPATITE B

    AIR LIQUIDE SANTE INT [FR] Β· Granted Dec 4, 2003 Β· Expires Nov 29, 2023

    expired
  11. US 6656474

    Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  12. US 6656706

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  13. US 6656465

    Antibodies that mimic actions of neurotrophins

    The Regents of the University of California Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  14. US 6656471

    HIV-specific T-cell induction

    The Board of Regents of the University of Texas System Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  15. US 6655379

    Aerosolized active agent delivery

    Nektar Therapeutics Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  16. US 6656746

    Antibodies to human kunitz-type inhibitor

    The Regents of the University of New Mexico Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  17. US 6656963

    Indole-3-carbinol (I3C) derivatives and methods

    The Regents of the University of California Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  18. US 6656939

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  19. US 6656917

    Compositions and methods for targeted enzymatic release of cell regulatory compounds

    Marker Gene Technologies, Inc Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  20. US 6656930

    Aralkyl diazabicycloalkane derivatives for CNS disorders

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  21. US 6656915

    Inhibiting T-cell proliferation

    BioCryst Pharmaceuticals, Inc. Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  22. US 6656714

    Nucleic acids and proteins of a rat ganglioside GM1-specific &agr;1→2 fucosyltransferase and uses thereof

    Northwest Hospital Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  23. US 6657104

    Transgenic mouse model for cardiac hypertrophy and methods of use thereof

    Texas Systems, University of the Board of the Regents Β· Granted Dec 2, 2003 Β· Expires Nov 27, 2023

    expired
  24. US 6653131

    Method of treating systemic inflammatory response syndrome

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.